PEPTONIC medical AB (FRA:28L) Cyclically Adjusted Book per Share: €0.04 (As of Mar. 2026)


What is PEPTONIC medical AB Cyclically Adjusted Book per Share?

PEPTONIC medical AB FRA:28L Cyclically Adjusted Book per Share is €0.04 as of Mar. 2026. The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

PEPTONIC medical AB's adjusted book value per share for the three months ended in Mar. 2026 was €0.000. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.04 for the trailing ten years ended in Mar. 2026.

During the past 12 months, PEPTONIC medical AB's average Cyclically Adjusted Book Growth Rate was -31.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-07), PEPTONIC medical AB's current stock price is €0.0002. PEPTONIC medical AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €0.04. PEPTONIC medical AB's Cyclically Adjusted PB Ratio of today is 0.01.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PEPTONIC medical AB was 0.13. The lowest was 0.01. And the median was 0.01.


PEPTONIC medical AB  (FRA:28L) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

PEPTONIC medical AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.0002/0.04
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PEPTONIC medical AB was 0.13. The lowest was 0.01. And the median was 0.01.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


PEPTONIC medical AB Cyclically Adjusted Book per Share Related Terms


PEPTONIC medical AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for PEPTONIC medical AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PEPTONIC medical AB Cyclically Adjusted Book per Share Chart

PEPTONIC medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.01 0.00 0.00

PEPTONIC medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.04

FRA:28L vs ZTS, UTHR, VTRS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PEPTONIC medical AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PEPTONIC medical AB Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PEPTONIC medical AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PEPTONIC medical AB's Cyclically Adjusted PB Ratio falls into.



PEPTONIC medical AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PEPTONIC medical AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0/133.5600*133.5600
=0.000

Current CPI (Mar. 2026) = 133.5600.

PEPTONIC medical AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.054 101.019 0.071
201609 0.052 101.138 0.069
201612 0.048 102.022 0.063
201703 0.047 102.022 0.062
201706 0.044 102.752 0.057
201709 0.034 103.279 0.044
201712 0.031 103.793 0.040
201803 0.028 103.962 0.036
201806 0.023 104.875 0.029
201809 0.021 105.679 0.027
201812 0.020 105.912 0.025
201903 0.018 105.886 0.023
201906 0.028 106.742 0.035
201909 0.020 107.214 0.025
201912 0.021 107.766 0.026
202003 0.019 106.563 0.024
202006 0.018 107.498 0.022
202009 0.017 107.635 0.021
202012 0.024 108.296 0.030
202103 0.023 108.360 0.028
202106 0.021 108.928 0.026
202109 0.014 110.338 0.017
202112 0.010 112.486 0.012
202203 0.013 114.825 0.015
202206 0.009 118.384 0.010
202209 0.008 122.296 0.009
202212 0.007 126.365 0.007
202303 0.004 127.042 0.004
202306 0.004 129.407 0.004
202309 0.003 130.224 0.003
202312 0.003 131.912 0.003
202403 0.002 132.205 0.002
202406 0.001 132.716 0.001
202409 0.001 132.304 0.001
202412 0.001 132.987 0.001
202503 0.000 132.825 0.000
202506 0.000 133.699 0.000
202509 0.000 133.480 0.000
202512 0.000 133.390 0.000
202603 0.000 133.560 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €0.04 mean?
PEPTONIC medical AB (FRA:28L) has a Cyclically Adjusted Book per Share of €0.04 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PEPTONIC medical AB and its competitors.
Is PEPTONIC medical AB's Cyclically Adjusted Book per Share too high?
PEPTONIC medical AB's current Cyclically Adjusted Book per Share is €0.04.
How does PEPTONIC medical AB's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
PEPTONIC medical AB's Cyclically Adjusted Book per Share of €0.04 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PEPTONIC medical AB and its competitors. PEPTONIC medical AB's current Cyclically Adjusted Book per Share is €0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PEPTONIC medical AB stock overvalued right now?
PEPTONIC medical AB (FRA:28L) has a current Cyclically Adjusted Book per Share of €0.04. The current Cyclically Adjusted Book per Share is €0.04. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For PEPTONIC medical AB (FRA:28L), the current Cyclically Adjusted Book per Share is €0.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PEPTONIC medical AB Business Description

Other Exchanges PMED:Sweden
Address Gustavslundsvagen 143, Bromma, SWE, SE-167 51
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.